Renal Toxicity Evaluation and Comparison Between Visipaque (Iodixanol) and Hexabrix (Ioxaglate) in Patients With Renal Insufficiency Undergoing Coronary Angiography: The RECOVER Study: A Randomized Controlled Trial
- 5 September 2006
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 48 (5), 924-930
- https://doi.org/10.1016/j.jacc.2006.06.047
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Cost-effectiveness of iodixanol in patients at high risk of contrast-induced nephropathyAmerican Heart Journal, 2005
- Contrast nephropathy: Review focusing on preventionJournal of the American College of Cardiology, 2004
- Nephrotoxic Effects in High-Risk Patients Undergoing AngiographyNew England Journal of Medicine, 2003
- Hospital-acquired renal insufficiencyAmerican Journal of Kidney Diseases, 2002
- The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiencyJournal of the American College of Cardiology, 2000
- Effects of contrast media and mannitol on renal medullary blood flow and red cell aggregation in the rat kidneyKidney International, 1996
- Nephrotoxicity of ionic and nonionic contrast media in 1196 patients: A randomized trialKidney International, 1995
- A randomized comparison of the nephrotoxicity of iopamidol and diatrizoate in high risk patients undergoing cardiac angiographyJournal of the American College of Cardiology, 1991
- Effect of Various Contrast Media on Coagulation, Fibrinolysis, and Platelet FunctionInvestigative Radiology, 1986
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976